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Background
End stage renal disease (ESRD) patients suffer high cardio-
vascular mortality rates with fibrosis-induced arrhythmia
recognized as a leading contributor. Since ESRD patients
are contraindicated to standard gadolinium-based fibrosis
imaging, non-contrast cardiac magnetic resonance ima-
ging (CMR) techniques could improve diagnosis and
empower evaluation of emerging anti-fibrotic therapies.
With remodeling and increased extracellular water
volume, a corresponding and measurable loss of magneti-
zation transfer (MT) occurs. We previously demonstrated
the ability to identify tissue that enhances with gadolinium
based on differences between pairs of differentially MT-
weighted balanced steady state free precession (bSSFP)
images1,2 (Figure 1A-C). In this study, we seek to apply
non-contrast MT-based tissue characterization in ESRD
patients.
Methods
ESRD patients on routine hemodialysis and healthy con-
trols (n = 9/group to date) were imaged on a 1.5T Siemens
Aera scanner. Pairs of prospectively gated cine bSSFP
images were obtained at flip angles of 50 and 45° from
base to apex [TR/TE=35.64/1.36 ms, FOV=260 × 260
mm2, Matrix=256 × 256, Thickness=8 mm, phases set to
fill the cardiac interval]. Maps of ΔS/So were generated as
ΔS/So=(S45-S5)/S5*100 (%), where Si is the signal intensity
per voxel at flip angle i. We analyzed cardiac structure and
global function. A custom feature tracking algorithm mea-
sured circumferential and longitudinal strains. The distri-
bution of ΔS/So values across all controls was used to
define a reference standard. To account for variations in
heart size, this distribution was dynamically resized to
simulate a cumulative distribution function of ΔS/So
matching the number of voxels per individual heart. Each
subject’s observed ΔS/So distribution was compared to the
appropriately-sized healthy standard using a one-sided
Kolmogorov-Smirnov (KS) test.
Results
While septal wall thickness was heightened in ESRD
patients (Table 1), ejection fraction and peak circumferen-
tial and longitudinal strains were similar to controls. A
sample ΔS/So map in an ESRD patient (Figure 1E) demon-
strates scattered enhancement compared to a healthy con-
trol (Figure 1D). Corresponding ΔS/So distributions
(Figure 1F) reveal a right skew in the ESRD patient, consis-
tent with tissue remodeling. KS analysis revealed a trend
toward greater rightward shift for ESRD patients
(avg=13%, range: 3-48%) than controls (avg=4%: 0-12%, p
= 0.12 vs. ESRD) when compared to the healthy standard.
Four ESRD patients and only 1 control displayed ΔS/So
distributions that diverged from the standard distribution
by more than 10%.
Conclusions
MT-weighted bSSFP imaging revealed a promising trend
towards elevated ΔS/So values in ESRD patients compared
to controls, despite preserved contractile function. Analy-
sis of ΔS/So distributions may provide a rapid and endo-
genous mechanism for myocardial tissue characterization
in ESRD patients. Ongoing participant recruitment will
increase sample sizes and may reveal additional patholo-
gies in ESRD patients.
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Figure 1 Tissue characterization with MT-weighted bSSFP. (A) End diastolic anatomical reference and (B) late gadolinium enhancement
(LGE) image from a patient with chronic myocardial infarction reveal an area of fibrotic scar tissue (red arrow). (C) The corresponding map of
ΔS/So acquired using MT-weighted CMR demonstrates elevated ΔS/So in the area identified as enhanced at LGE (images reprinted from prior
validation study [1,2]). (D) Map of ΔS/So for a healthy control revealts low values throughout the left ventrical. (E) In contrast, a maps of ΔS/So in
an ESRD patient reveals diffusely elevated values throughout the left ventricle, with several focal areas demonstrating values consistent with
tissues that would enhance at LGE. (F) Representative cumulative distribution frequency plots of ΔS/So values for participants in D (orange) and E
(red). For each participant a simulated healthy standard distribution (black) was used to adjust for differences in heart size. A one-sided
Komogorov-Smirnov test revealed a significant (p < 0.001) rightward shift in the ESRD patient (negative differential statistic = 14%) compared to
no observable difference in the control subject (2%, N.S. vs healthy standard).
Table 1 Participant Characteristics, Function, and
Mechanics Results
Variable Control (n = 9) ESRD (n = 9)
Age (yrs.) 52.0 ± 5.0 53.3 ± 17.0
Male 6 5
Dialysis Vintage (yrs.) n/a 5.5 ± 2.3
BMI (kg/m2) 23.8 ± 1.5 31.3 ± 5.3**
Heart Rate at MRI (bpm) 58 ± 13 71 ± 10*
Ejection Fraction (%) 56.4 ± 4.7 62.6 ± 7.7
End Diastolic Septal Thickness (mm) 8.8 ± 0.1 13.2 ± .3**
Peak Circumferential Strain 29.6 ± 6.5 30.2 ± 6.6
Peak Longitudinal Strain 22.1 ± 3.4 20.9 ± 3.5
Mean per Subject ΔS/So (%) 135.9 ± 12.8 150.6 ± 25.1
BMI: Body Mass Index, *p < 0.05, **p < 0.01 vs. ESRD.
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